We anticipate a high level of demand for our products, as they will allow labs to save money, time and

Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments

Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample

Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup

We anticipate a high level of demand for our products, as they will allow labs to save money, time and

Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments

Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample

Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup